Press Release Summary:
Operating in conjunction with laboratory information system, DL2000 v6.4 facilitates patient test result management. Clinical labs can consolidate test information from various instrument systems and manage data in real-time. Able to control multiple lab processes, software performs auto-validation based on user-defined criteria and alerts operator to abnormal results. Reflex testing and delta checking can be performed automatically.
Original Press Release:
Beckman Coulter's New Version of DL2000 Data Manager Boasts Enhanced Features for Improved Laboratory Workflow
FULLERTON, Calif. (March 24, 2005) – Giving a boost to its burgeoning information systems (IS) product line, Beckman Coulter, Inc. has released DL2000 Version 6.4, an update to its innovative data management software that improves laboratory workflow and patient test result management. DL2000 operates in conjunction with a laboratory information system (LIS), enabling clinical labs to consolidate test information from various instrument systems and manage the data in real time. With DL2000, operators can control multiple lab processes, from sample tube identification to test result validation. New software features include the ability to link Beckman Coulter hematology instrument systems, including the company’s COULTER® LH 750 and COULTER LH 500 hematology analyzers. Independent of hematology workstations, the interface can connect Beckman Coulter’s SYNCHRON® and UniCel® DxC chemistry analyzers, Access® family of immunoassay systems, Array® 360CE system, Paragon CZE® 2000 clinical capillary electrophoresis system, IMMAGE® immunochemistry systems and Power Processor automation system. A single DL2000 unit can link up to three Beckman Coulter systems. By networking additional DL2000 units, laboratories can connect even more instruments. To improve patient safety and lab efficiency, the data manager reduces manual review of test results by performing auto-validation based on user-defined criteria. The system alerts the operator when abnormal, critical or unexpected results are generated. Reflex testing and delta checking can be performed automatically based on single or multiple test results. DL2000 can perform automatic sample re-run. Also, DL2000’s automatic stat notification eliminates processing delays and speeds delivery of critical sample results to clinicians. Future plans for DL2000 include an optional extended quality control (EQC) module, which will offer comprehensive QC for connected chemistry, immunoassay, protein and capillary electrophoresis systems. The EQC module will features Westgard rules with Levey-Jennings charts, patient-moving averages, exponentially weighted moving averages and more. DL2000 is available exclusively from Beckman Coulter in the United States. The software is marketed by Beckman Coulter as Remisol 2000 throughout Europe as well as in Canada, Australia, New Zealand and South Africa. In addition to DL2000, Beckman Coulter’s IS solutions include Command Central, which enables operators to control and monitor multiple Beckman Coulter laboratory instruments from a single workstation. Beckman Coulter, Inc. is a leading manufacturer of biomedical testing instrument systems, tests and supplies that simplify and automate laboratory processes. Spanning the biomedical testing continuum — from pioneering medical research and clinical trials to laboratory diagnostics and point-of-care testing — Beckman Coulter’s 200,000 installed systems provide essential biomedical information to enhance health care around the world. The company, based in Fullerton, Calif., reported 2004 annual sales of $2.4 billion with 64 percent of this amount generated by recurring revenue from supplies, test kits and services. For more information, visit www.beckmancoulter.com or call (800) 352-3433.